The Company has enclosed herewith intimation under regulation 30 regarding order received from Central Goods and Service Act,2017

Regulatory & Legal View source PDF Explain this filing

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹1344.00

prior close

₹1351.90

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.4%-1.4% vs market

Pharmaceuticals peers, median of 150sector+0.6%-1.7% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Midcap 150 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-0.5

15m

-0.3

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0+0.4-1.4+0.6-1.7

Next day

+3.3+1.1+2.2+1.4+1.9

+2.2+0.9+1.2+1.4+0.8

+2.5+0.9+1.7+1.0+1.6

+5.4+1.0+4.3+1.0+4.3

+6.2+1.0+5.2+1.6+4.5

+9.2+0.6+8.6+0.6+8.7

15d

+9.4+0.5+8.9+3.8+5.5

+10.1-2.0+12.1+0.9+9.2

+5.7-4.1+9.7-3.7+9.4

-2.2-3.4+1.2-3.6+1.4

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ipca Laboratories has received an Order in Original (OIO) from the Superintendent of CGST & CX, Jorethang Range under Section 74 of the Central Goods and Service Tax Act, 2017, covering financial years 2019-20 to 2021-22. The order upholds a tax demand of Rs. 8,81,224 along with applicable interest under Section 50 and a penalty of an equal amount of Rs. 8,81,224. The allegation relates to Input Tax Credit (ITC) availed and utilized allegedly in contravention of Section 16(4) or 17(5) of the CGST Act. The total monetary exposure including tax, interest, and penalty is approximately Rs. 17.6 lakhs. The company has stated that this demand will have no material impact on its financials, operations, or other activities, and plans to file an appeal within the prescribed timelines.

Likely market impact

The financial impact is negligible given the relatively small demand amount (under Rs. 18 lakhs total) compared to IPCA's scale, and the company has already indicated it will contest the order. Shareholders are unlikely to see any meaningful effect on stock price or business operations.